Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: Technoloy
No Comments
The AGILE platform is a collaboration between the University of Liverpool, the Liverpool School of Tropical Medicine, and the Southampton Clinical Trials Unit that aims to speed…
By Pharmatrax Author
Category: News
No Comments
Biopharma company Immuron (IMC) has received U.S. Food and Drug Administration (FDA) guidance for a new investigational drug designed to treat diarrhoea. The drug is…
By Pharmatrax Author
Category: News
No Comments
The discovery of new biomarkers other than amyloid or tau is an optimistic sign for Alzheimer’s drug development, according to an expert on clinical research…
By Pharmatrax Author
Category: Technoloy
No Comments
Drug discovery approaches can be broadly divided into two categories – target-based and phenotypic screening. Historically, medicines were selected for their visible (or perceived) health benefits,…
By Pharmatrax Author
Category: Technoloy
No Comments
A team of researchers from Nagoya City University, Japan, has developed a new type of 3D bioprinted drug delivery system, leveraging fish gelatin. The gelatin is…
By Pharmatrax Author
Category: News
No Comments
all. We hope you’re hanging tough and that your week is off to a splendid start. As for the news cycle — things could be…
By Pharmatrax Author
Category: News
No Comments
On the heels of a carcinogen scare that drove the company to pull three lots of a short-term ulcer treatment in January, Mylan has issued…
By Pharmatrax Author
Category: News
No Comments
A sixth company has recalled its version of Type 2 diabetes drug Metformin Hydrochloride Extended Release Tablets 750 mg after finding some of the medicine…
By Pharmatrax Author
Category: Technoloy
No Comments
Keith Murphy, CEO of Viscient Biosciences, discusses the process of developing a 3D bioprinted tissue model and their potential in developing therapeutics for COVID-19 and…
By Pharmatrax Author
Category: Technoloy
No Comments
According to the World Health Organization (WHO), 1 in 10 medical products “is substandard or falsified” in developing nations. In Afghanistan, the numbers are staggeringly higher and…